Bortezomib (velcade(R))-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem-cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma (MM)

被引：33

作者：

Cavo, Michele ^{[1
]}

Patriarca, Francesca ^{[2
]}

Tacchetti, Paola ^{[1
]}

Galli, Monica ^{[2
]}

Perrone, Giulia ^{[1
]}

Petrucci, Maria Teresa ^{[2
]}

Brioli, Annamaria ^{[1
]}

Bringhen, Sara ^{[2
]}

Pantani, Lucia ^{[1
]}

Tosi, Patrizia ^{[1
]}

Crippa, Claudia ^{[2
]}

Zamagni, Elena ^{[1
]}

Di Raimondo, Francesco ^{[2
]}

Narni, Franco ^{[2
]}

Cellini, Claudia ^{[2
]}

Ceecolini, Michela ^{[1
]}

Pescosta, Norbert ^{[2
]}

Goldaniga, Maria Cecilia ^{[2
]}

Montefusco, Vittorio ^{[2
]}

Callea, Vincenzo ^{[2
]}

De Stefano, Valerio ^{[2
]}

Caravita, Tommaso ^{[2
]}

Boccadoro, Mario ^{[2
]}

Baccarani, Michele ^{[1
]}

机构：

[1] Univ Bologna, Seragnoli Inst Hematol, Bologna, Italy

[2] Italian Myeloma Network, Gimema, Italy

来源：

关键词：

D O I：

10.1182/blood.V110.11.73.73

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：30A / 30A

页数：1